In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B

ABRIDGE, an AI Startup Automing Medical Notes, has a series E of $ 300 million according to the $ 5.3 billion, according to the Wall Street Journal. De Ronde, led by Andreessen Horowitz with the participation of Khosla Ventures, follows the $ 250 million of the company February Fundraise With a rating of $ 2.75 billion.

The seven-year-old Abridge is generally considered the leader in the ever-drilled AI-driven medical writer market, largely because of the early entry And integration with Epic Systems, the dominant software for health records.

In the first quarter, Abridge reached $ 117 million in contracted annual return income (a metric that includes all signed contacts, including from customers who are still not on board)) The reported information last month.

Together with the fundraising, Abridge announced that it is spreading to converting medical notes from patient agreements into AI-driven medical codes, an offer that makes the company directly competing with startups such as Codametrix and a function of his partner Epic systems.

Abridge, founded by cardiologist Shiv Rao, claims that his AI Scribe technology is used by more than 150 of the largest health systems in the US.